October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Ruben Mesa: Deeply proud of Brenda Crump for their innovation and impact of the Immediate Infusion Clinic
May 14, 2024, 13:41

Ruben Mesa: Deeply proud of Brenda Crump for their innovation and impact of the Immediate Infusion Clinic

Ruben Mesa shared a post by Wake Forest Center for Healthcare Innovation on LinkedIn, adding:

”Deeply proud of Brenda Crump and our team at Levine Cancer for their innovation and impact of the Immediate Infusion Clinic (IIC), grateful for this award to further expand and refine the concept!”

Quoting Wake Forest Center for Healthcare Innovation’s post:

The Center for Healthcare Innovation and Advocate Enterprise Population Health Services is excited to announce the and offer congradulations to the 2024 LAUNCH Program Finalists!

  • Infusion Immediate Care (IIC)
    Brenda Crump
    Atrium Health, North Carolina – Charlotte Region
  • Leveling Up Digital Care for the Emergency General Surgery (EGS) Patient
    Caroline Reinke
    Atrium Health, North Carolina – Charlotte Region
  • Safe Tether: Mobility Tracking App
    Craig Jankuski
    Advocate Health, Wisconsin
  • RADTP (Rehabilitation Adult Day Treatment Program)
    Robert G. Larrison and Mike Duchaj
    Atrium Health, North Carolina – Charlotte Region
    Advocate Health, Illinois

Again we want to say THANK YOU to everyone who applied and to read more details on each of the four finalist’s projects, see project descriptions.”

Wake Forest Center for Healthcare Innovation

Source: Ruben Mesa/LinkedIn and Wake Forest Center for Healthcare Innovation/LinkedIn

Dr. Ruben A. Mesa, MD, FACP, serves as the president and executive director of Atrium Health Levine Cancer Institute (LCI) and Atrium Health Wake Forest Baptist Comprehensive Cancer Center. Additionally, he holds the position of vice dean for cancer programs and professor of medicine at Wake Forest University School of Medicine. He is an international expert in hematologic cancers, particularly myeloproliferative neoplasms (MPNs). Through his tireless efforts, Dr. Mesa continues to drive progress in the understanding and treatment of hematologic malignancies, offering hope to those affected by these complex diseases.